|
|
|
|
|
AI Design Input, HTP Data
Output Accelerating AI-Designed Sequence to
Antibody Candidates
|
|
|
|
Sino Biological has established an integrated, high-throughput technology platform specifically designed to accelerate AI-driven lead discovery and optimization. Our platform combines automated, high-throughput antibody production systems—including mammalian cell expression and cell-free protein synthesis—with comprehensive developability assessment tools. This enables the rapid synthesis of thousands of AI-derived antibody variants, generating large volumes of high-quality datasets essential for training and enhancing AI models. By seamlessly translating AI-designed sequences into viable therapeutic candidates, the platform bridges the gap between computational design and experimental validation.
|
|
Learn More about HTP Platform for AI-Driven Antibody Discovery 
|
|
General Workflow of AI-driven Lead Discovery
|
|
|
|
Sino Biological leverages its integrated platform for high-throughput antibody production and developability assessment to help clients solve the wet lab bottleneck in AI-driven antibody discovery and accelerate the generation of high-quality data. Learn More 
|
|
|
|
WHY CHOOSE OUR HTP Production & Analytics Platform?
|
|
|
 Customized service
Customers provide the sequence information of the target antibody
|
|
|
Efficient construction
The automated platform supporting rapid gene synthesis and vector construction
|
|
|
|
Comprehensive format support
Supporting multiple antibody formats: IgG, scFv-His, VHH-Fc, VHH-His, mini-binders, among others
|
|
|
Over 10 developability assays
Covering affinity, homogeneity, stability, polyspecificity, hydrophobicity, and more
Click to View Details >>>
|
|
|
|
As fast as 5 days
Mammalian & cell-free expression platforms enable gene-to-antibody in as fast as 5 days
|
|
|
18+ years of experience
Your trusted partner with strong expertise in recombinant antibody production
|
|
|
Contact Us to Get a Quote Right Now
|
|
|
|
Case Studies
|
|
|
Cell-free Platform: HTP scFv-His/VHH-His Synthesis for AI Screening
|
|
|
Format: 2000+ scFv-His and VHH-His antibodies
Expression system: CFPS
Target: Finished expression and affinity analysis with different target proteins by BLI
Timeline: 3-4 weeks
|
|
Reducing SDS-PAGE (Partial)
|
|
|
|
BLI Result (Partial)
|
|
KD: <1.0E-12M
|
KD: <1.0E-12M
|
|
|
|
|
|
|
|
|
Mammalian Expression Platform: HTP Gene to Antibody Production of various IgG
|
|
|
|
|
Purity: 99.5% by SEC-HPLC
Expression system: HEK293
|
|
|
|
Purity: 100% by SEC-HPLC
Expression system: HEK293
|
|
|
|
Purity: 99.7% by SEC-HPLC
Expression system: HEK293
|
|
|
|
|
|
|
Don’t Miss Out!
|
|
Kinase Drug Discovery Solutions >>
|
|
Center for Bioprocessing (C4B)
US-Based Recombinant Production >>
|
|
|
|
